| # | Drug | Count |
|---|---|---|
| 0 | ESTRADIOL | 44 |
| 1 | ESTRADIOL GEL 0.1% | 19 |
| 2 | ESTRADIOL TRANSDERMAL | 19 |
| 3 | ESTRADIOL, | 19 |
| 4 | LEVOTHYROXINE SODIUM | 13 |
| 5 | ESTROGENS, CONJUGATED | 8 |
| 6 | LEUPROLIDE ACETATE | 8 |
| 7 | CONJUGATED ESTROGENS | 7 |
| 8 | LEVONORGESTREL | 7 |
| 9 | QUETIAPINE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LITHIUM CARBONICUM | 1 | 0.0106 |
| 1 | ALOE FEROX LEAF | 1 | 0.0055 |
| 2 | ESTRADIOL CYPIONATE | 2 | 0.0034 |
| 3 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 4 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 5 | SEGESTERONE ACETATE AND ETHINYL ESTRADIOL | 1 | 0.0026 |
| 6 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 7 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 8 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 1 | 0.0011 |
| 9 | FOLLITROPIN ALFA | 2 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 55 |
| 1 | Benzodiazepine [EPC] | 11 |
| 2 | Aromatase Inhibitor [EPC] | 10 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 4 | Progestin [EPC] | 10 |
| 5 | Kinase Inhibitor [EPC] | 8 |
| 6 | Atypical Antipsychotic [EPC] | 7 |
| 7 | Progestin-containing Intrauterine System [EPC] | 7 |
| 8 | Estrogen Receptor Antagonist [EPC] | 6 |
| 9 | Progesterone [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Estrogen [EPC] | 55 | 0.0003 |
| 2 | Progesterone [EPC] | 6 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 4 | Estrogen Receptor Antagonist [EPC] | 6 | 0.0001 |
| 5 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 7 | Aromatase Inhibitor [EPC] | 10 | 0.0001 |
| 8 | Androgen [EPC] | 2 | 0.0001 |
| 9 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |